Skip to main content
AmigoFish

Reengineering Chemotherapy for Solid Tumors...Lew Bender, Founder, President & CEO, Intensity Therapeutics

From BioTech Nation ... with Dr. Moira Gunn · · 18 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.

Back to BioTech Nation ... with Dr. Moira Gunn · Report a problem